Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00003-2/abstract?utm_campaign=update-landia&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_landia&_hsenc=p2ANqtz-9hOqYEdK1n8b-pmoMpjQAPRXD-QswAtuLz7aEAa3xARrl8MCSiixvkmoekmAjmXRQA0Oi-nDkm4Xt0ax_ecx49QegALg&_hsmi=300884856&utm_content=300846354&utm_source=hs_email